Nomad P-KAFO Study
Cerebrovascular Accident, Post-polio Syndrome, Spinal Cord Injuries
About this trial
This is an interventional treatment trial for Cerebrovascular Accident
Eligibility Criteria
Inclusion Criteria: Regular and compliant use of a unilateral or bilateral KAFO or SCO or other passive KAFOs for impairment due to neurological or neuromuscular disease, orthopedic disease, or trauma Cognitive ability to understand and follow the study protocol; willingness to provide informed consent Willing to wear and charge an activity monitor for three-months home trials. Exclusion Criteria: Flexion contracture in the knee and/or hip joint in excess of 15 degrees Non-correctable knee varus/valgus in excess of 15 degrees Severe spasticity Inability to stabilize the trunk with or without assistive devices (crutches, canes, etc.)
Sites / Locations
- Shirley Ryan AbilityLab
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group A
Group B
Group A receives the intervention Nomad KAFO first; fitting & training will occur with the intervention and will then be used for a 3 month home trial, followed by outcomes testing. Group A then will cross over and train with their own Traditional Assistive Device and will then use their own device for a 3 month home trial, followed by outcomes testing.
Group B receives training in their own Traditional Assistive Device first; training will occur with their own Traditional Assistive Device and will then use their own device for a 3 month home trial, followed by outcomes testing. Group B then will cross over and receive the intervention Nomad KAFO; fitting & training will occur with the intervention and will then be used for a 3 month home trial, followed by outcomes testing.